Purchase Order 75N91023P00782
Award Date 8/17/23
Potential Completion Date 1/5/24
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Oxford Nanopore Technologies, Inc. was awarded a $13,500 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to provide equipment maintenance services under contract number 1253541. The contract has a period of performance from January 2024 through February 2025 for maintenance of equipment located in New York, New York. No set-aside designation or subcontractors were identified. The National Cancer Institute...
- The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), awarded a $50,105 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc. for the procurement of a GridION instrument and license to support DNA and RNA sequencing research within the Division of Cancer Epidemiology and Genetics (DCEG), Laboratory of Translational Genomics. The contract has an ultimate completion date of November 29, 2024...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,950 purchase order to Intera Oncology Inc. for laboratory equipment. The firm fixed price contract has a period of performance from September 6, 2023 through October 28, 2023 and will be performed in Wellesley Hills, Massachusetts. No additional details were provided regarding the specific laboratory equipment being procured. The National Cancer Institute conducts and supports...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,381.70 firm fixed price purchase order to Illumina, Inc. for unspecified products or services. The place of performance will be in Bethesda, Maryland through September 2023. Illumina will deliver the requested items or work to support the National Cancer Institute, part of the NIH focused on cancer research, treatment, and initiatives to reduce the public health burden of cancer....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $15,000 purchase order to 10X Genomics, Inc. for service agreement work. 10X Genomics will perform the services at its Pleasanton, California location from September 2023 through September 2024 under a firm fixed price contract. No additional details were provided on the scope of work requested under the solicitation. The National Cancer Institute supports research to advance cancer...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $20,481 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts for biological products and services. The firm fixed price contract runs from November 13, 2023 through December 26, 2023 and will support the NIH NCI's research efforts. No subcontractors or set aside designations were identified. Olink Proteomics will provide biological materials to aid the NIH NCI in...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded Roche Diagnostics Corporation a $20,463.87 firm fixed price delivery order for reagents and consumables. The contract has no set-aside designation and runs through January 13, 2023. As the largest biomedical research agency in the world, the National Cancer Institute works with both public and private partners to better understand, diagnose, and treat cancer. This delivery order...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $15,000 purchase order to Evident Scientific, Inc. of Waltham, Massachusetts for laboratory equipment. The firm fixed price contract runs from September 21, 2023 through December 22, 2023 and will provide equipment to support the NIH NCI's research efforts. No subcontractors or set aside designations were identified. The award utilizes the governmentwide acquisition contract vehicle and...